- Marketwired•last monthPlandai Biotechnology Announces Agreement in Principal for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes
Plandaí Biotechnology, Inc. , producer of the highly bioavailable Phytofare® catechin complex, today announced that it has reached an agreement in principal with North West University in South Africa, ...
- Marketwired•3 months agoPlandai Biotechnology Files 10-K for 2015, Discusses Future Filings, 2016 Operating Results, and Company Future
Plandaí Biotechnology, Inc. , producer of the highly bioavailable Phytofare® catechin complex, today discussed the recent filing of the Company's financial statements for the year ended June 30, 2015, ...
- Marketwired•3 months ago
Plandaí Biotechnology, Inc. , producer of the highly bioavailable Phytofare® catechin complex, today announced it has registered the Company and its products on the Branded Ingredients website as a further ...
Plandaí Biotechnology, Inc. (PLPL)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.01 - 0.01|
|52wk Range||0.01 - 0.13|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.54|
|Avg Vol (3m)||734,821|
|Dividend & Yield||N/A (N/A)|